Pharmacokinetic metrics CL, Vd and F [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2017-05-06 14:14 (2545 d 12:38 ago) – Posting: # 17309
Views: 10,080

Hi MMW,

❝ As per the Guideline, for CFDA submissions, …


This one (page 17)?

F = 100×AUCT/AUCR.

If the drug exhibits linear PK and different doses are administered a correction is suggested

F = 100×(AUCT×DR)/(AUCR×DT).


❝ … pharmacokinetic parameters CL, Vd and F needs to be submitted.


<nitpicking>

pharmacokinetic modeling → PK parameters
noncompartmental analysis → PK metrics

</nitpicking>

❝ Can we calculate these parameters in Phoenix software?


If you have a Phoenix/WinNonlin license, please RTFM. ;-)

To calculate ƒ (absolute bioavailability after an extravascular dose) you need a crossover study with EV vs. IV doses. Better is simultaneous administration of EV and stable isotope labeled IV – which requires cGMP of the IV dose (that’s a big obstacle). Then

ƒ = (AUC∞,EV×DIV)/(AUC∞,IV×DEV) and
F (%) = 100ƒ.

Note that ƒ calculated from a crossover study assumes constant inter-occasion clearances, which might not be correct (especially for highly variable drugs*).
CL and Vd are only accessible after an intravenous dose, where

CL = D/AUC and
Vd = D/C0.

Without ƒ (i.e., only EV dosing) you get just CL/ƒ and Vd/ƒ, which IMHO is of limited value since ƒ is unknown. Both are given in the standard output of Phoenix/WinNonlin. Report them to make the CFDA happy (irrelevant in BE) but please not as CL and V.



Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,656 registered users;
113 visitors (0 registered, 113 guests [including 6 identified bots]).
Forum time: 02:53 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5